プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
imnm is clinically characterized by persistent proximal muscle weakness and elevated serum creatine kinase, which persist despite discontinuation of statin treatment.
imnm hija kkaratterizzata klinikament b’dgħjufija persistenti tal-muskoli prossimali u b’żieda fil-creatine kinase fis-serum, li jibqgħu preżenti minkejja li jitwaqqa t-trattament bl-istatini.
最終更新: 2017-04-26
使用頻度: 1
品質:
in patients where the use of systemic fusidic acid is considered essential, statin treatment should be discontinued throughout the duration of fusidic acid treatment.
f'pazjenti fejn l-użu ta' fusidic acid sistemiku huwa meqjus essenzjali, il-kura bi statins għandha titwaqqaf tul il-kura kollha bi fusidic acid.
最終更新: 2017-04-26
使用頻度: 1
品質:
if a patient has previously experienced a muscle disorder on a fibrate or a statin, treatment with a different member of the class should only be initiated with caution.
jekk fil-passat pazjent ikun esperjenza disturb fil-muskoli b’fibrat jew bi statin, kura b’membru differenti tal-klassi tal-mediċina għandha tinbeda biss b’kawtela.
最終更新: 2017-04-26
使用頻度: 1
品質:
if statin treatment is required during the treatment period, a switch to a reduced dose of pravastatin/rosuvastatin is possible (see section 4.5, table 2).
jekk il-kura bi statin huwa meħtieġ waqt il-perijodu ta’ kura, tnaqqis fid-doża ta' pravastatin/rosuvastatin huwa possibbli (ara sezzjoni 4.5, tabella 2).
最終更新: 2017-04-26
使用頻度: 1
品質:
personal history of myopathy and/or rhabdomyolysis with statins and/or fibrates or confirmed creatine phosphokinase (ck) elevation above 5 times the uln under previous statin treatment (see section 4.4).
storja personali ta’ mijopatija u/jew rhabdomyolysis bi statins u/jew fibrati jew elevazzjoni ta’ creatine phosphokinase (ck) ikkonfermata, ogħla minn 5 darbiet il-uln taħt kura minn qabel bi statin (ara sezzjoni 4.4).
最終更新: 2017-04-26
使用頻度: 1
品質:
personal history of myopathy and/or rhabdomyolysis with statins and/or fibrates or confirmed creatine phosphokinase elevation above 5 times the upper limit of normal (uln) under previous statin treatment (see section 4.4)
passat mediku personali ta’ mijopatija u/jew rabdomijolisi b’statins u/jew fibrati jew żieda kkonfermata fil-creatine phosphokinase ta’ aktar minn 5 darbiet l-ogħla limitu tan-normal (uln) taħt kura preċedenti b’statin (ara sezzjoni 4.4)
最終更新: 2017-04-26
使用頻度: 1
品質:
関係性の低い人による翻訳は非表示になります。
関係性の低い結果を表示します。